Evidence map›Paper›PMID 31836851›Full record

ArticleLeukemia2020

Correction: Bidirectional linkage between the B-cell receptor and NOTCH1 in chronic lymphocytic leukemia and in Richter's syndrome: therapeutic implications.

Francesca Arruga, Valeria Bracciamà, Nicoletta Vitale, Tiziana Vaisitti, Katiuscia Gizzi, Alison Yeomans, Marta Coscia, Giovanni D'Arena, Gianluca Gaidano, John N Allan and 4 more

Abstract readPublished Erratum
PubMed Publisher
In one paragraph

Article in Leukemia, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

14 authors.

Francesca ArrugaDepartment of Medical Sciences, University of Turin, Turin, Italy. francesca.arruga@unito.it.
Valeria BracciamàDepartment of Medical Sciences, University of Turin, Turin, Italy.
Nicoletta VitaleDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Tiziana VaisittiDepartment of Medical Sciences, University of Turin, Turin, Italy.
Katiuscia GizziItalian Institute for Genomic Medicine, IIGM, Turin, Italy.
Alison YeomansCancer Sciences Unit, Haematological Oncology Group, University of Southampton, Southampton, UK.
Marta CosciaDepartment of Molecular Biotechnology and Health Sciences, University of Turin, Turin, Italy.
Giovanni D'ArenaHematology and Stem Cell Transplantation Unit, IRCCS Referral Cancer Center of Basilicata, Rionero in Vulture, Italy.
Gianluca GaidanoDivision of Hematology, Department of Translational Medicine, University of Eastern Piedmont, Novara, Italy.
John N AllanDepartment of Hematology, Weill Cornell Medicine, New York, NY, USA.
Richard R FurmanDepartment of Hematology, Weill Cornell Medicine, New York, NY, USA.
Graham PackhamCancer Sciences Unit, Haematological Oncology Group, University of Southampton, Southampton, UK.
Francesco ForconiCancer Sciences Unit, Haematological Oncology Group, University of Southampton, Southampton, UK.ORCID http://orcid.org/0000-0002-2211-1831
Silvia DeaglioDepartment of Medical Sciences, University of Turin, Turin, Italy. silvia.deaglio@unito.it.ORCID http://orcid.org/0000-0003-0632-5036

Funding

Cancer Research UK 29370
6 · The paper itself

Abstract

An amendment to this paper has been published and can be accessed via a link at the top of the paper.

Identifiers

PMID31836851

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.